Table 1.
Patients’ characteristics of the learning cohort and validation cohort
| Parameter |
Learning cohort (n = 50) |
Validation cohort (n = 101) |
||
| mean | SD | mean | SD | |
| Male | 37 | 73 | ||
| Female | 13 | 28 | ||
| Age (yr) | 55.8 | 10.8 | 53.2 | 10.6 |
| BMI (kg/m²) | 26.0 | 4.4 | 25.4 | 4.2 |
| GOT (U/L) | 135.2 | 99.9 | 95.0 | 76.0 |
| GPT (U/L) | 104.6 | 173.4 | 90.2 | 133.7 |
| GGT (U/L) | 591.1 | 828.0 | 568.6 | 762.8 |
| AP (U/L) | 129.8 | 102.7 | 131.9 | 110.4 |
| Bilirubin (mg/dL) | 2.1 | 3.3 | 2.0 | 3.9 |
| Albumin (g/dL) | 4.0 | 0.6 | 4.0 | 0.7 |
| Protein (g/dL) | 7.0 | 0.7 | 7.0 | 0.8 |
| Quick (%) | 98.5 | 19.5 | 95.3 | 20.8 |
| INR | 1.0 | 0.2 | 1.0 | 0.2 |
| Urea | 32.5 | 42.5 | 27.1 | 31.8 |
| Creatinine (mg/dL) | 0.9 | 0.5 | 0.8 | 0.4 |
| PTT (s) | 34.9 | 7.6 | 35.1 | 7.9 |
| Hb (g/dL) | 13.7 | 1.9 | 13.5 | 2.0 |
| Hk (%) | 39.9 | 5.3 | 39.7 | 5.6 |
| Erythrocytes (/pL) | 4.1 | 0.6 | 4.0 | 0.6 |
| Leukocytes (/nL) | 7.0 | 2.0 | 7.3 | 2.9 |
| Thrombocytes (/nL) | 202.5 | 99.2 | 204.5 | 112.5 |
| Glucose (mg/dL) | 100.1 | 20.7 | 97.2 | 18.9 |
| HbA1C (%) | 5.7 | 1.7 | 5.5 | 1.3 |
| Triglycerides (mg/dL) | 222.4 | 259.5 | 204.1 | 208.8 |
| Cholesterin (mg/dL) | 217.5 | 51.8 | 212.5 | 63.6 |
| Ferritin (ng/mL) | 636.3 | 580.7 | 671.7 | 589.4 |
| Transferrin (g/L) | 2.2 | 0.4 | 2.1 | 0.5 |
| Iron (μg/dL) | 109.0 | 51.9 | 107.1 | 59.6 |
| CRP (mg/dL) | 2.2 | 3.8 | 2.3 | 3.1 |
| Alcohol (g/d) | 144.1 | 106.1 | 146.8 | 100.8 |
| LS (kPa) | 20.1 | 24.3 | 20.4 | 22.4 |
GOT: Glutamic oxaloacetic transaminase; GGT: γ glutamyl transferase; GPT: Glutamic pyruvic transaminase; AP: Alkaline phosphatase; INR: International normalized ratio; PTT: Prothrombin time; Hb: Hemoglobin; Hk: Hematocrit; HbA1C: Glycosylated Hb; CRP: C-reactive protein; LS: Liver stiffness; BMI: Body mass index.